Overall rank by patents
#31,785
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 9 technology areas, recorded in grant years 2020–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Glysens ranks #31,785 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 9 technology areas.
USPTO PatentsView assignee plate
Corpus R31785 · US Corporation #31,785 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: GlaxoSmithKline Consumer Healthcare GmbH and Co. KG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
GlySens Incorporated · this assignee
35 score
3D Lighting… · lowest
7 score
What this shows Glysens's Innovation Score is 35.4/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
GlySens Incorporated is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (6 grants) versus a trough of 2 in 2022. By volume, Glysens sits between GlaxoSmithKline Consumer Healthcare GmbH and Co. KG and GoKnown LLC.
GlySens Incorporated shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
GlaxoSmithKline Consumer Healthcare GmbH and Co. KG
8 patents
Glean Technologies, Inc.
8 patents
Global Algae Technology, LLC
8 patents
Global Energy Science, LLC
8 patents
Go Papa, Lllp
8 patents
Go Team CCR, LLC
8 patents
GoFire, Inc.
8 patents
GoKnown LLC
8 patents
GlySens Incorporated
8 patents
What this shows GlySens holds 8 patents at rank #31,816, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,816 in granted patent volume.
Other assignees with the most granted patents in GlySens's primary technology class.
Glysens's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 49% higher than 51% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 6 | 75.0% |
| 2022 | 2 | 25.0% |
Top 9 of 9 technology areas
Overall rank by patents
#31,785
of 49,997 tracked assignees
35.4 out of 100
What to do with this data
GlySens Incorporated's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.